Evidence map›Paper›PMID 38034030›Full record

ArticleMolecular therapy. Nucleic acids2023

Intradermal DNA vaccine delivery using vacuum-controlled, needle-free electroporation.

Alison Generotti, Ryne Contreras, Brenden Zounes, Eric Schade, Andrea Kemme, Yatish Rane, Xinggang Liu, Dustin Elwood, Katherine Schultheis, Jeremy Marston and 3 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Nano-delivery platforms for bacterial gene transformation: suitability and challenges.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Alison GenerottiInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Ryne ContrerasInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Brenden ZounesInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Eric SchadeInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Andrea KemmeInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Yatish RaneTexas Tech University, Department of Chemical Engineering, Lubbock, TX 79409, USA.
Xinggang LiuInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Dustin ElwoodInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Katherine SchultheisInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Jeremy MarstonTexas Tech University, Department of Chemical Engineering, Lubbock, TX 79409, USA.
Jay McCoyInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Kate BroderickInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Paul FisherInovio Pharmaceuticals, Inc., San Diego, CA 92121, USA.
Inovio Pharmaceuticals (United States) · USTexas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intradermal delivery of DNA vaccines via electroporation (ID-EP) has shown clinical promise, but the use of needle electrodes is typically required to achieve consistent results. Here, delivery of a DNA vaccine targeting the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is achieved using noninvasive intradermal vacuum-EP (ID-VEP), which functions by pulling a small volume of skin tissue into a vacuum chamber containing noninvasive electrodes to perform EP at the injection site. Gene expression and immunogenicity correlated with EP parameters and vacuum chamber geometry in guinea pigs. ID-VEP generated potent humoral and cellular immune responses across multiple studies, while vacuum (without EP) greatly enhanced localized transfection but did not improve immunogenicity. Because EP was performed noninvasively, the only treatment site reaction observed was transient redness, and ID-VEP immune responses were comparable to a clinical needle-based ID-EP device. The ID-VEP delivery procedure is straightforward and highly repeatable, without any dependence on operator technique. This work demonstrates a novel, reliable, and needle-free delivery method for DNA vaccines.

Indexed as

DNA vaccineElectroporationMT: Delivery Strategiesnucleic acid deliveryskinsuctiontransfectionvacuum

Identifiers

PMID38034030
PMCPMC10682253
OpenAlexW4388037348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.